# CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

> **NCT05066789** · PHASE4 · TERMINATED · sponsor: **Samsung Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Type of stent
- **DRUG:** Duration of DAPT

## Key facts

- **NCT ID:** NCT05066789
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-17
- **Primary completion:** 2024-03-22
- **Final completion:** 2024-03-22
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** Ending early registration due to low registration status and lack of research
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05066789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05066789, "CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05066789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*